Miyakogusa Predicted Gene
- Lj4g3v0165070.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj4g3v0165070.1 tr|G7J5G3|G7J5G3_MEDTR Serine-protein kinase ATM
OS=Medicago truncatula GN=MTR_3g077860 PE=4
SV=1,86.82,0,PI3_4_KINASE_3,Phosphatidylinositol 3-/4-kinase,
catalytic domain; FAT,PIK-related kinase; no descri,CUFF.46661.1
(580 letters)
Database: TAIR10_pep
35,386 sequences; 14,482,855 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
AT3G48190.1 | Symbols: ATM, ATATM | ataxia-telangiectasia mutate... 923 0.0
AT5G40820.1 | Symbols: ATRAD3, ATR, ATATR | Ataxia telangiectasi... 149 6e-36
AT1G50030.1 | Symbols: TOR | target of rapamycin | chr1:18522626... 94 3e-19
AT1G50030.2 | Symbols: TOR | target of rapamycin | chr1:18522626... 94 3e-19
>AT3G48190.1 | Symbols: ATM, ATATM | ataxia-telangiectasia mutated |
chr3:17797628-17828361 FORWARD LENGTH=3845
Length = 3845
Score = 923 bits (2385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/586 (74%), Positives = 518/586 (88%), Gaps = 19/586 (3%)
Query: 1 MAINLAMYISQNYQSTKEASDVHRLVGKWLAETRSSNSRTILEKYLKPAVTIAEDVNT-T 59
++I+LA YI NYQ +EASD++R++GKWLAETRSSNSRTILEKYL+PAV++AE+ ++
Sbjct: 3132 VSISLANYILHNYQLKEEASDIYRVIGKWLAETRSSNSRTILEKYLRPAVSLAEEQSSKI 3191
Query: 60 DKKTMERKCQTHFHLAHYSDALFRSHEERLTSNEWQAAMRLRKHKTVELEALIKRLRSST 119
K+ ++R+ QT FHLAHY+DALF+S+EERL+S+EWQAA+RLRKHKT ELEA
Sbjct: 3192 CKRLVDRQSQTWFHLAHYADALFKSYEERLSSSEWQAALRLRKHKTKELEA--------- 3242
Query: 120 KGEKTDYTMKIQELQKQVAMDKEEAEKLQDDRDNFFSLALEGYKRCLVIGDKYDVRVVFR 179
E++DY++KIQ+LQKQ+ MDKEEAEKLQ DRDNF LALEGYKRCL IGDKYDVRVVFR
Sbjct: 3243 --EQSDYSLKIQDLQKQLTMDKEEAEKLQVDRDNFLKLALEGYKRCLEIGDKYDVRVVFR 3300
Query: 180 IVSLWFSLSTRKHVVSSMLTAIDEVQSFKFIPLVYQIASRMGSSKDGQGPHNFQFALVSL 239
VS+WFSL+++K+V+ +ML+ I EVQS+KFIPLVYQIASR+GSSKD G ++FQ ALVSL
Sbjct: 3301 QVSMWFSLASQKNVIDNMLSTIKEVQSYKFIPLVYQIASRLGSSKDESGSNSFQSALVSL 3360
Query: 240 VKKMAIDHPYHTILQLLALANGDRIKDKQRSRSSFVVDMDKKLAAENLLNELSSYHGAII 299
++KMAIDHPYHTILQLLALANGDRIKD QRSR+SFVVDMDKKLAAE+LL ++S YHG +I
Sbjct: 3361 IRKMAIDHPYHTILQLLALANGDRIKDNQRSRNSFVVDMDKKLAAEHLLQDVSHYHGPMI 3420
Query: 300 GQMKQMVEIYIKLAEMETKREDTNRRVTLPRDLRNLPVLELVPVVTATISIDRSCQYQEG 359
QMKQ+V+IYIKLAE+ET+REDTNR+V LPR++R++ LELVPVVTATI +DRSCQY EG
Sbjct: 3421 RQMKQLVDIYIKLAELETRREDTNRKVALPREIRSVKQLELVPVVTATIPVDRSCQYNEG 3480
Query: 360 TFPYFKGLADSVMIMNGINAPKVVECLGSDGCRYRQLAKSGNDDLRQDAVMEQFFDL--- 416
+FP+F+GL+DSV +MNGINAPKVVEC GSDG +Y+QLAKSGNDDLRQDAVMEQFF L
Sbjct: 3481 SFPFFRGLSDSVTVMNGINAPKVVECFGSDGQKYKQLAKSGNDDLRQDAVMEQFFGLVNT 3540
Query: 417 ----HRDTWRRRLGIRTYKVVPFTPSAGVLEWVNGTLPLGEYLIGSMRNGGAHGRYGVGD 472
+RDTW+RRL +RTYKV+PFTPSAGVLEWV+GT+PLG+YLIGS R+ GAHGRYG+G+
Sbjct: 3541 FLHNNRDTWKRRLAVRTYKVIPFTPSAGVLEWVDGTIPLGDYLIGSSRSEGAHGRYGIGN 3600
Query: 473 WSFLKCREHMANERDKRKAFQEVCGNFRPVMHYFFLERFSQPAEWFEKRLAYTRSVAASS 532
W + KCREHM++ +DKRKAF +VC NFRPVMHYFFLE+F QPA+WF KRLAYTRSVAASS
Sbjct: 3601 WKYPKCREHMSSAKDKRKAFVDVCTNFRPVMHYFFLEKFLQPADWFVKRLAYTRSVAASS 3660
Query: 533 MVGYIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLMLKTPERV 578
MVGYIVGLGDRH+MNILIDQATAEVVHIDLGVAFEQGLMLKTPERV
Sbjct: 3661 MVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERV 3706
>AT5G40820.1 | Symbols: ATRAD3, ATR, ATATR | Ataxia
telangiectasia-mutated and RAD3-related |
chr5:16343860-16353847 REVERSE LENGTH=2702
Length = 2702
Score = 149 bits (376), Expect = 6e-36, Method: Compositional matrix adjust.
Identities = 150/616 (24%), Positives = 252/616 (40%), Gaps = 121/616 (19%)
Query: 11 QNYQSTKEASDVHR---LVGKWLAETRSSNSRTILEKYLKPAVTIAEDVNTTDKKTMERK 67
+N QS KE DV + L KW+ + + +L Y T K +
Sbjct: 2040 RNTQSFKEKKDVAKTLLLYSKWIHHSGQKQKKDVLNLY-------------TQVKELLPW 2086
Query: 68 CQTHFHLAHYSDALFRSHEERLTSNEWQAAMRLRKHKTVELEALIKR--LRSSTKGEKT- 124
+ +FHLA Y D L+ A + ++ +V A K+ + S+ EK
Sbjct: 2087 EKGYFHLAKYYDELYVD------------ARKCQQESSVFSSAGSKKGSVSSNLSTEKAG 2134
Query: 125 -DYTMKIQELQKQVAMDKEEAEKLQDDRDNFFSLALEGYKRCLVIGDKYDVRVVFRIVSL 183
DY K + Y + L G K + + R+++L
Sbjct: 2135 WDYLFK----------------------------GMYFYAKALHSGHKNLFQALPRLLTL 2166
Query: 184 WFSL----------------STRKHVVSSMLTAIDEVQSFKFIPLVYQIASRMGSSKDGQ 227
WF ST ++S M + ++ +++++ ++ Q+ SR+
Sbjct: 2167 WFDFGTIYKTSGSAGNKELKSTHMKIMSLMRGCLKDLPTYQWLTVLPQLVSRICH----- 2221
Query: 228 GPHNFQFALVSLVKKMAIDHPYHTILQ----LLALANGDRIKDKQRSRSSFVVDMDKKLA 283
Q A L+ K I H Q ++A + + ++ + + +
Sbjct: 2222 -----QNADTVLMVKNIITSVLHQFPQQGLWIMAAVSKSTVPARREAAAEIIQ------G 2270
Query: 284 AENLLNELSSYHGAIIGQMKQMVEIYIKLA---------EMETKREDTNRRVTLPRDLRN 334
A N+ H I Q + + +IKL + E + + +P D+
Sbjct: 2271 ARKGFNQSDRGHNLFI-QFASLTDHFIKLCFHGGQPRSKVINIATEFSALKRMMPLDII- 2328
Query: 335 LPVLELVPVVTATISIDRSCQYQEGTF-----PYFKGLADSVMIMNGINAPKVVECLGSD 389
+P+ + + + ++ + ++ F P G+AD I++ + PK + LG+D
Sbjct: 2329 MPIQQSLTISLPAFHMNNNERHSASVFSGSDLPTISGIADEAEILSSLQRPKKIILLGND 2388
Query: 390 GCRYRQLAKSGNDDLRQDAVMEQFFDL-------HRDTWRRRLGIRTYKVVPFTPSAGVL 442
G Y L K DDLR+DA M +F + + ++ RR+L IRT+ V P T G++
Sbjct: 2389 GIEYPFLCKP-KDDLRKDARMMEFTAMINRLLSKYPESRRRKLYIRTFAVAPLTEDCGLV 2447
Query: 443 EWVNGTLPLGEYLIGSMRNGGAHGRYGVGDWSFLKCREHMANERDKRKAFQEVCGNFRPV 502
EWV T L L + G R + + A +++ ++ F PV
Sbjct: 2448 EWVPHTRGLRHILQDIYISCGKFDRQKTNP-QIKRIYDQCAVKKEYEMLKTKILPMFPPV 2506
Query: 503 MHYFFLERFSQPAEWFEKRLAYTRSVAASSMVGYIVGLGDRHSMNILIDQATAEVVHIDL 562
H +FL FS+PA WF R+AY + A SMVG+IVGLGDRH NIL D + + VH+D
Sbjct: 2507 FHKWFLTTFSEPAAWFRSRVAYAHTTAVWSMVGHIVGLGDRHGENILFDSTSGDCVHVDF 2566
Query: 563 GVAFEQGLMLKTPERV 578
F++GL L+ PE V
Sbjct: 2567 SCLFDKGLQLEKPELV 2582
>AT1G50030.1 | Symbols: TOR | target of rapamycin |
chr1:18522626-18539619 REVERSE LENGTH=2481
Length = 2481
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 371 VMIMNGINAPKVVECLGSDGCRYRQLAKSGNDDLRQDAVMEQFFDL-------HRDTWRR 423
++++ P+ + G+DG Y L K G++DLRQD + Q F L R T +
Sbjct: 2069 LVVITSKQRPRKLTIHGNDGEDYAFLLK-GHEDLRQDERVMQLFGLVNTLLENSRKTAEK 2127
Query: 424 RLGIRTYKVVPFTPSAGVLEWVNGTLPLGEYLIGSMRNG--------GAHGRYGVGDWSF 475
L I+ Y V+P +P++G++ WV L +LI R+ H D+
Sbjct: 2128 DLSIQRYSVIPLSPNSGLIGWVPNCDTL-HHLIREHRDARKIILNQENKHMLSFAPDYDN 2186
Query: 476 LKCREHMANERDKRKAFQEVCGNFRPVMHYFFLERFSQPAEWFEKRLAYTRSVAASSMVG 535
L +A A + GN + +L+ S W E+R YTRS+A SMVG
Sbjct: 2187 LPL---IAKVEVFEYALENTEGN--DLSRVLWLKSRSSEV-WLERRTNYTRSLAVMSMVG 2240
Query: 536 YIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLML-KTPERV 578
YI+GLGDRH N+++ + + +++HID G FE + K PE+V
Sbjct: 2241 YILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKV 2284
>AT1G50030.2 | Symbols: TOR | target of rapamycin |
chr1:18522626-18539619 REVERSE LENGTH=2454
Length = 2454
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 371 VMIMNGINAPKVVECLGSDGCRYRQLAKSGNDDLRQDAVMEQFFDL-------HRDTWRR 423
++++ P+ + G+DG Y L K G++DLRQD + Q F L R T +
Sbjct: 2042 LVVITSKQRPRKLTIHGNDGEDYAFLLK-GHEDLRQDERVMQLFGLVNTLLENSRKTAEK 2100
Query: 424 RLGIRTYKVVPFTPSAGVLEWVNGTLPLGEYLIGSMRNG--------GAHGRYGVGDWSF 475
L I+ Y V+P +P++G++ WV L +LI R+ H D+
Sbjct: 2101 DLSIQRYSVIPLSPNSGLIGWVPNCDTL-HHLIREHRDARKIILNQENKHMLSFAPDYDN 2159
Query: 476 LKCREHMANERDKRKAFQEVCGNFRPVMHYFFLERFSQPAEWFEKRLAYTRSVAASSMVG 535
L +A A + GN + +L+ S W E+R YTRS+A SMVG
Sbjct: 2160 LPL---IAKVEVFEYALENTEGN--DLSRVLWLKSRSSEV-WLERRTNYTRSLAVMSMVG 2213
Query: 536 YIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLML-KTPERV 578
YI+GLGDRH N+++ + + +++HID G FE + K PE+V
Sbjct: 2214 YILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKV 2257